Incidence of Venous Thromboembolism and the Impact on Survival in Breast Cancer Patients
- 1 January 2007
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (1) , 70-76
- https://doi.org/10.1200/jco.2006.07.4393
Abstract
Purpose The incidence of venous thromboembolism (VTE) and the risk factors associated with development of VTE have not been reported in a large population-based study of breast cancer patients. Pat...Keywords
This publication has 29 references indexed in Scilit:
- Venous Thromboembolism in Patients With Colorectal Cancer: Incidence and Effect on SurvivalJournal of Clinical Oncology, 2006
- Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common CancersArchives of internal medicine (1960), 2006
- Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996Thrombosis and Haemostasis, 2005
- Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee ArthroplastyArchives of internal medicine (1960), 1998
- Comorbidity Measures for Use with Administrative DataMedical Care, 1998
- Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1997
- Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.Journal of Clinical Oncology, 1996
- Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.Journal of Clinical Oncology, 1994
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989